Related Experiment Videos
[Basedow's neuropathy].
1Clinique Ophtalmologique, CHU Bretonneau, Tours.
Bulletin Des Societes D'Ophtalmologie De France
|June 1, 1990
Summary
Grave's neuropathy can occur in treated patients with hypothyroidism. Corticosteroids initially resolved symptoms, but recurrence necessitated orbital radiotherapy, highlighting varied treatment approaches for dysthyroid neuropathy.
Area of Science:
- Neurology
- Endocrinology
- Ophthalmology
Background:
- Grave's disease is an autoimmune disorder often associated with thyroid dysfunction.
- Dysthyroid neuropathy is a rare complication of Grave's disease, presenting with neurological deficits.
- Hypothyroidism can exacerbate or unmask neurological symptoms in patients with Grave's disease.
Observation:
- A case report details a patient with Grave's neuropathy experiencing symptom onset during biologically induced hypothyroidism despite prior treatment.
- Initial treatment with corticosteroids led to complete remission of the neuropathy.
- Reduced corticosteroid dosage resulted in disease recurrence, indicating a need for alternative or supplementary therapies.
Findings:
- The patient's neuropathy resolved with corticotherapy, suggesting an inflammatory or immune-mediated component responsive to steroids.
- Recurrence upon dose reduction highlights the chronic and potentially relapsing nature of dysthyroid neuropathy.
- Orbital radiotherapy was required to manage the recurrent symptoms, indicating its efficacy in refractory cases.
Implications:
- This case underscores the complex interplay between thyroid status and neurological manifestations in Grave's disease.
- It suggests that corticotherapy is a viable initial treatment for dysthyroid neuropathy, but long-term management may require adjustments.
- Orbital radiotherapy presents a potential therapeutic option for recurrent or refractory dysthyroid neuropathy, warranting further investigation.